Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients

Summary

Thrombosis occurring in the small intrahepatic, as well as in the large vessels is involved in the progression of cirrhosis. Anticoagulation could reduce morbidity and mortality in cirrhotic patients

Timeline

Start

2015-07-27

Primary completion

2019-07-02

Completion

2019-07-02

Outcome

Outcome not reported

Stopped: “Premature discontinuation of inclusions by the sponsor for low inclusion”

Drugs

Indications